Feedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System

The p53 transcription factor is a regulator of key cellular processes including DNA repair, cell cycle arrest, and apoptosis. In this theoretical study, we investigate how the complex circuitry of the p53 network allows for stochastic yet unambiguous cell fate decision-making. The proposed Markov chain model consists of the regulatory core and two subordinated bistable modules responsible for cell cycle arrest and apoptosis. The regulatory core is controlled by two negative feedback loops (regulated by Mdm2 and Wip1) responsible for oscillations, and two antagonistic positive feedback loops (regulated by phosphatases Wip1 and PTEN) responsible for bistability. By means of bifurcation analysis of the deterministic approximation we capture the recurrent solutions (i.e., steady states and limit cycles) that delineate temporal responses of the stochastic system. Direct switching from the limit-cycle oscillations to the “apoptotic” steady state is enabled by the existence of a subcritical Neimark—Sacker bifurcation in which the limit cycle loses its stability by merging with an unstable invariant torus. Our analysis provides an explanation why cancer cell lines known to have vastly diverse expression levels of Wip1 and PTEN exhibit a broad spectrum of responses to DNA damage: from a fast transition to a high level of p53 killer (a p53 phosphoform which promotes commitment to apoptosis) in cells characterized by high PTEN and low Wip1 levels to long-lasting p53 level oscillations in cells having PTEN promoter methylated (as in, e.g., MCF-7 cell line).

[1]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[2]  Jing Li,et al.  Wip1-deficient mice are resistant to common cancer genes. , 2004, Trends in molecular medicine.

[3]  T. Hofmann,et al.  Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR , 2008, Nature Cell Biology.

[4]  Keng Boon Wee,et al.  Akt versus p53 in a network of oncogenes and tumor suppressor genes regulating cell survival and death. , 2006, Biophysical journal.

[5]  R. Parsons,et al.  The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. , 1998, Cancer research.

[6]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[7]  J. Ptak,et al.  High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.

[8]  P. Donahoe,et al.  Requirement for phosphatidylinositol-3'-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse. , 1999, Endocrinology.

[9]  David J. Arenillas,et al.  Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer , 2008, Journal of Cell Science.

[10]  Eshel Ben-Jacob,et al.  MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.

[11]  C. Prives,et al.  Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.

[12]  D. Gillespie Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[13]  M. Oren,et al.  mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.

[14]  Cristina M. Pinto,et al.  Retracted: Frequent genetic and biochemical alterations of the PI 3‐K/AKT/PTEN pathway in head and neck squamous cell carcinoma , 2005, International journal of cancer.

[15]  Akira Nakagawara,et al.  PPM1D is a potential target for 17q gain in neuroblastoma. , 2003, Cancer research.

[16]  M. Rocchi,et al.  Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene. , 1994, Genomics.

[17]  Paul Brazhnik,et al.  Exploring Mechanisms of the DNA-Damage Response: p53 Pulses and their Possible Relevance to Apoptosis , 2007, Cell cycle.

[18]  G. Lahav,et al.  Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. , 2008, Molecular cell.

[19]  E. Stavridi,et al.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Qian Yang,et al.  Nuclear Factor-κB (NF-κB) Is a Novel Positive Transcriptional Regulator of the Oncogenic Wip1 Phosphatase* , 2009, The Journal of Biological Chemistry.

[21]  Tomasz Lipniacki,et al.  Levels of pro-apoptotic regulator Bad and anti-apoptotic regulator Bcl-xL determine the type of the apoptotic logic gate , 2013, BMC Systems Biology.

[22]  D R Alessi,et al.  PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.

[23]  T. Hofmann,et al.  Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. , 2007, Cancer research.

[24]  U Alon,et al.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Ginsberg,et al.  E2F1 Modulates p38 MAPK Phosphorylation via Transcriptional Regulation of ASK1 and Wip1* , 2006, Journal of Biological Chemistry.

[26]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[27]  Y Taya,et al.  Enhanced phosphorylation of p53 by ATM in response to DNA damage. , 1998, Science.

[28]  George Lliakis,et al.  The role of DNA double strand breaks in lonizing radiation‐induced killing of eukaryotic cells , 1991 .

[29]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[30]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[31]  James R Faeder,et al.  Rule-based modeling of biochemical systems with BioNetGen. , 2009, Methods in molecular biology.

[32]  J C Reed,et al.  Dysregulation of apoptosis in cancer. , 1998, The cancer journal from Scientific American.

[33]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[34]  Xiongbin Lu,et al.  The Wip1 phosphatase and Mdm2: Cracking the "Wip" on p53 stability , 2008, Cell cycle.

[35]  Frank McCormick,et al.  High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. , 2005, Cancer research.

[36]  John Jeremy Rice,et al.  A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Xin Huang,et al.  Somatic mutation and gain of copy number of PIK3CA in human breast cancer , 2005, Breast Cancer Research.

[38]  Kyucheol Cho,et al.  Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma , 2003, International journal of cancer.

[39]  Daniel Isnardon,et al.  TP53INP1s and Homeodomain-interacting Protein Kinase-2 (HIPK2) Are Partners in Regulating p53 Activity* , 2003, Journal of Biological Chemistry.

[40]  Giulia Piaggio,et al.  Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.

[41]  James E. Ferrell,et al.  A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision , 2007, Nature.

[42]  Bo Stenerlöw,et al.  Measurement of Prompt DNA Double-Strand Breaks in Mammalian Cells without Including Heat-Labile Sites: Results for Cells Deficient in Nonhomologous End Joining , 2002, Radiation research.

[43]  Se Jin Jang,et al.  The Estrogen Receptor α Pathway Induces Oncogenic Wip1 Phosphatase Gene Expression , 2009, Molecular Cancer Research.

[44]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[45]  G. Wahl,et al.  MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.

[46]  M. Fiscella,et al.  Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Joel Keizer,et al.  Statistical Thermodynamics of Nonequilibrium Processes , 1987 .

[48]  Wei Gu,et al.  p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.

[49]  Albert J. Fornace,et al.  Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase , 2006, The Journal of experimental medicine.

[50]  Wei Wang,et al.  Two-phase dynamics of p53 in the DNA damage response , 2011, Proceedings of the National Academy of Sciences.

[51]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[52]  Zdenek Kolar,et al.  Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells. , 2006, Anticancer research.

[53]  Masahiro Nakagawa,et al.  Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. , 2011, Blood.

[54]  Päivikki Kauraniemi,et al.  The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours , 2006, Breast Cancer Research and Treatment.

[55]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[56]  Zigang Dong,et al.  Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.

[57]  F. E. Bertrand,et al.  CBF-1 (RBP-Jk) Binds to the PTEN Promoter and Regulates PTEN Gene Expression , 2007, Cell cycle.

[58]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[59]  Wei Wang,et al.  Coordination between Cell Cycle Progression and Cell Fate Decision by the p53 and E2F1 Pathways in Response to DNA Damage* , 2010, The Journal of Biological Chemistry.

[60]  Y Taya,et al.  DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization , 1999, The EMBO journal.

[61]  Tomasz Lipniacki,et al.  Oscillations and bistability in the stochastic model of p53 regulation. , 2008, Journal of theoretical biology.

[62]  Takashi Kumagai,et al.  PTEN promoter is methylated in a proportion of invasive breast cancers , 2004, International journal of cancer.

[63]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[64]  Ettore Appella,et al.  ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing Radiation* , 2002, The Journal of Biological Chemistry.

[65]  P. Peltomäki,et al.  Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma , 2007, International journal of cancer.

[66]  J Downward,et al.  PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. , 1997, Trends in biochemical sciences.

[67]  Kai Rothkamm,et al.  Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle , 2003, Molecular and Cellular Biology.

[68]  S. Knuutila,et al.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.

[69]  平沢 晃,et al.  Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets , 2004 .

[70]  Pier Paolo Pandolfi,et al.  The PTEN–PI3K pathway: of feedbacks and cross-talks , 2008, Oncogene.

[71]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[72]  Xiongbin Lu,et al.  The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. , 2007, Cancer cell.

[73]  G. Iliakis,et al.  The role of DNA double strand breaks in ionizing radiation-induced killing of eukaryotic cells. , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.

[74]  S. Leibler,et al.  Biological rhythms: Circadian clocks limited by noise , 2000, Nature.

[75]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[76]  Anthony J. Davis,et al.  Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites , 2009, The Journal of cell biology.

[77]  Kunihiko Kaneko,et al.  Molecular discreteness in reaction-diffusion systems yields steady states not seen in the continuum limit. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[78]  Ryan A. Kellogg,et al.  Spontaneous NF-κB Activation by Autocrine TNFα Signaling: A Computational Analysis , 2013, PloS one.

[79]  Gideon Rechavi,et al.  HIPK2 modulates p53 activity towards pro-apoptotic transcription , 2009, Molecular Cancer.

[80]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[81]  Nathalie Perreault,et al.  The PTEN Phosphatase Controls Intestinal Epithelial Cell Polarity and Barrier Function: Role in Colorectal Cancer Progression , 2010, PloS one.

[82]  Alberto Gandolfi,et al.  The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise , 2014, PLoS Comput. Biol..

[83]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[84]  Toshiyuki Obata,et al.  Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53* , 2002, The Journal of Biological Chemistry.

[85]  S. Elmore Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[86]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[87]  Ettore Appella,et al.  Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites , 2008, Nucleic acids research.

[88]  J. Ferrell,et al.  A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision , 2003, Nature.

[89]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[90]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[91]  Andrius Kazlauskas,et al.  The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase , 1995, Cell.

[92]  Lawrence A. Donehower,et al.  Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D , 2007, Journal of Neuro-Oncology.

[93]  Kim Sneppen,et al.  Multistability with a metastable mixed state. , 2012, Physical review letters.

[94]  L. Mayo,et al.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[95]  Edda Klipp,et al.  Systems Biology , 1994 .

[96]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[97]  Albert J. Fornace,et al.  Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis , 2005, Cancer biology & therapy.

[98]  Eshel Ben-Jacob,et al.  Turning Oscillations Into Opportunities: Lessons from a Bacterial Decision Gate , 2013, Scientific Reports.

[99]  Z. Cheng,et al.  Cell fate decision mediated by p53 pulses , 2009, Proceedings of the National Academy of Sciences.

[100]  G. Selivanova,et al.  Pharmacological reactivation of p53 as a strategy to treat cancer , 2015, Journal of internal medicine.

[101]  Uttam Surana,et al.  Oscillations of the p53-Akt Network: Implications on Cell Survival and Death , 2009, PloS one.

[102]  E. Kandel,et al.  The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. , 1999, Experimental cell research.

[103]  T. Lipniacki,et al.  Exploring mechanisms of oscillations in p53 and nuclear factor-B systems. , 2009, IET systems biology.

[104]  F. Schlögl,et al.  J. Keizer: “Statistical Thermodynamics of Nonequilibrium Processes”, Springer‐Verlag, New York, Berlin, Heidelberg, London, Paris, Tokyo 1987. 506 Seiten, Preis: DM 128,–. , 1989 .

[105]  C Béroud,et al.  p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis , 2000, Human mutation.

[106]  A. Arkin,et al.  Stochastic amplification and signaling in enzymatic futile cycles through noise-induced bistability with oscillations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[107]  R. Milo,et al.  Oscillations and variability in the p53 system , 2006, Molecular systems biology.

[108]  G. Panayotou,et al.  Phosphoinositide 3-kinases: a conserved family of signal transducers. , 1997, Trends in biochemical sciences.

[109]  Xin Ma,et al.  NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma. , 2013, Urologic oncology.

[110]  Masaaki Adachi,et al.  p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.

[111]  S. T. Kim,et al.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. , 2001, Genes & development.

[112]  Wayne A. Phillips,et al.  Mutation of the PIK3CA Gene in Ovarian and Breast Cancer , 2004, Cancer Research.

[113]  C Eng,et al.  PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. , 2001, Human molecular genetics.

[114]  William S. Hlavacek,et al.  Computational Analysis of an Autophagy/Translation Switch Based on Mutual Inhibition of MTORC1 and ULK1 , 2015, PloS one.

[115]  M. Ehrenberg,et al.  Stochastic focusing: fluctuation-enhanced sensitivity of intracellular regulation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[116]  U. Knippschild,et al.  Posttranslational modification of MDM2. , 2003, Molecular cancer research : MCR.

[117]  E. Yu,et al.  Expression of a Homeostatic Regulator, Wip1 (Wild-type p53-induced Phosphatase), Is Temporally Induced by c-Jun and p53 in Response to UV Irradiation* , 2010, The Journal of Biological Chemistry.

[118]  Lawrence A. Donehower,et al.  Mice Deficient for the Wild-Type p53-Induced Phosphatase Gene (Wip1) Exhibit Defects in Reproductive Organs, Immune Function, and Cell Cycle Control , 2002, Molecular and Cellular Biology.

[119]  Andrea Ciliberto,et al.  Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.

[120]  Li Mao,et al.  Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[121]  Mariano Provencio,et al.  Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype , 1999, Breast Cancer Research and Treatment.

[122]  R. Mirzayans,et al.  New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy , 2012, Journal of biomedicine & biotechnology.

[123]  Jeffrey R. Marks,et al.  Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.

[124]  Z. Weng,et al.  A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.

[125]  A. Knudson,et al.  Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[126]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[127]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[128]  E. Appella,et al.  Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.